Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-casd-3_07-cv-00633/USCOURTS-casd-3_07-cv-00633-2/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Personal Injury

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

cal sc 

1 07cv0633

UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF CALIFORNIA

MICHAEL O’CONNOR,

Plaintiff,

v.

BAYER CORPORARTION, 100 Bayer

Road, Crafton Pennsylvania 15202; BAYER

HEALTHCARE, 400 Morgan Lane, West

Have, Connecticut 06516; BAYER AG,

BAYERWERK, Gebaeude W11, KaiserWilhelm-allee 51368 Leverkusen, Germany,

Defendants. 

)

)

)

)

)

)

)

)

)

)

)

)

)

)

Civil No. 07cv633 LAB(AJB)

ORDER FOLLOWING CASE

MANAGEMENT CONFERENCE

On August 27, 2007, the Court convened a Case Management Conference in the above entitled

action. Appearing were Michael Lynch, Esq., Brian Barr, Esq. on behalf of plaintiff; Steve Darringer,

Esq., Katherine Barrad, Esq. and Richard Dandrea, Esq. on behalf of defendants.

In advance of the conference, counsel prepared and submitted a joint case management order and

a protective order. These will be issued separately. 

This is one of 14 lawsuits filed, to date, concerning the drug Trasylol. The 14 cases are pending

in various parts of the country, and others are expected to be filed. Some of the other cases are already

underway and counsel have found that there are millions of documents that need to be produced by the

defendants. Defense counsel is uniform Nationally. The parties are trying to coordinate depositions and

discovery to avoid repeat settings and counsel have agreed to start the depositions in early 2008. 

Case 3:07-cv-00633-LAB-AJB Document 18 Filed 08/28/07 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

K:\COMMON\BATTAGLI\CASES\o'connor\order.fcmc.827.wpd 2 07cv0633

Service is also pending on Bayer AG and it is expected to be complete by early 2008. Bayer AG will

have a host of additional documents and deposition requirements that will need to be addressed in the

litigation. 

The other cases are now set for trial starting in September 2009 and ranging through June 2010. 

After extended discussion with the parties, it is clear that a lengthy schedule is necessary here to

facilitate the coordination effort on the various cases and to orderly prepare the matter for what is 

shaping up to be a sequence of trials. 

While the scheduling proposed by the parties is unusually long for this Court, counsel have

sufficiently justified the need. Similar schedules have been adopted in the other cases to facilitate

coordination. Therefore the Court will enter a Case Management Order as agreed by the parties without

prejudice to later review or modification.

The Court and counsel discussed the prospect of settlement, and settlement cannot be pursued

until the entire universe of potential plaintiffs are better estimated and the expert analysis of the issues in

the litigation are more complete. The Court indicated its availability for settlement sessions as soon as

the parties are ready to proceed.

IT IS SO ORDERED.

DATED: August 28, 2007

Hon. Anthony J. Battaglia

U.S. Magistrate Judge

United States District Court

Case 3:07-cv-00633-LAB-AJB Document 18 Filed 08/28/07 Page 2 of 2